RIG-I通过促进p21降解促进食道状细胞癌的细胞增殖
Meng Wang1, Yangyang Zhang1, Liping Gao1
1Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China.
Medical oncology (Northwood, London, England)
|September 1, 2023
概括
网红酸诱导基因-I (RIG-I) 通过增强细胞增殖和通过p21降解加速细胞循环,促进食道状细胞癌 (ESCC) 的进展. RIG-I可能是ESCC的治疗目标.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 网红酸诱导基因-I (RIG-I) 是RNA病毒感染的关键传感器.
- 新出现的证据表明,RIG-I参与了致癌的产生.
- 在食道状细胞癌 (ESCC) 中RIG-I的具体作用尚不清楚.
研究的目的:
- 研究RIG-I在ESCC中的表达和功能.
- 阐明RIG-I影响ESCC进展的机制.
- 评估RIG-I作为ESCC的潜在治疗点.
主要方法:
- 在ESCC中使用公共数据库,免疫组织化学和西式涂抹对RIG-I表达的分析.
- 通过CCK-8,殖民地形成和EDU染色试验评估ESCC细胞增殖.
- 在异种移植模型中评估细胞循环动态,p21无化和体内瘤生长.
主要成果:
- 发现RIG-I在ESCC细胞中表达很高.
- 增加RIG-I表达显著促进ESCC细胞增殖和细胞周期进展.
- 在体内,RIG-I knockdown抑制了瘤生长,并与通过p21无化和降解加速细胞循环进展有关.
结论:
- 在ESCC中RIG-I表达升高通过促进p21无化和降解来加速癌症的进展.
- RIG-I在ESCC的发病过程中起着重要作用,并与患者的预后有关.
- RIG-I代表了食道状细胞癌治疗的有前途的新型治疗标.
相关概念视频
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K


